Ozone Exposure for Acute Lung Injury
(LOCONOZ2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how a small amount of ozone in the air affects lung function and symptoms in healthy young adults. Participants will breathe either clean air or air with a low concentration of ozone while engaging in moderate exercise. The researchers aim to observe any changes in breathing and lung inflammation. The trial seeks healthy individuals who can exercise moderately for several hours and have no history of asthma or recent respiratory illnesses. As a Phase 1 trial, this research focuses on how ozone exposure affects lung function, offering participants the chance to contribute to foundational scientific knowledge.
Do I need to stop taking my current medications to join the trial?
Yes, you may need to stop taking certain medications. The trial excludes participants taking mega doses of vitamins, supplements, homeopathic/naturopathic medicines, or medications that may impact the ozone challenge results, including systemic steroids and beta blockers. Other medications not mentioned may be reviewed by investigators before inclusion.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that ozone levels of 0.070 ppm can affect breathing. Studies have found that short-term exposure to high ozone levels might lead to increased breathing problems. Even lower levels, such as 60 parts per billion (ppb), can impact lung function.
Evidence also indicates that long-term ozone exposure can affect lung growth, particularly in children. Short-term exposure, as tested in this trial, might cause some breathing issues, though this is less certain.
Overall, while this study is in its early stages, it is important to recognize that ozone exposure can pose risks to lung health.12345Why are researchers excited about this trial's treatments?
Researchers are excited about this trial because it explores the impact of ozone exposure combined with moderate intermittent exercise on acute lung injury. Unlike current treatments that focus on medications or ventilatory support to manage symptoms, this approach investigates a potential environmental and physical intervention. By understanding how different ozone levels influence lung health during exercise, scientists aim to uncover new insights that could lead to novel preventive strategies or therapeutic methods for lung injury.
What evidence suggests that this trial's treatments could be effective for acute lung injury?
This trial will compare the effects of exposure to 0.070 ppm ozone concentration with exposure to clean air (0.0 ppm ozone) during moderate intermittent exercise. Research has shown that even low levels of ozone, like 0.070 ppm, can affect lung function and cause inflammation. One study found that ozone exposure led to small changes in lung function, such as a slight decrease in the amount of air exhaled quickly and the total air exhaled after a deep breath. However, these changes are usually minor and reversible. Other studies have shown that ozone exposure can cause breathing issues, including coughing and shortness of breath. While these effects are documented, the impact can vary from person to person.12367
Who Is on the Research Team?
Andy Ghio, M.D.
Principal Investigator
EPA/ORD/CPHEA/PHITD/CRB
Are You a Good Fit for This Trial?
Healthy adults aged 18-35 with normal lung function and the ability to do moderate exercise for 6.6 hours can join this trial. Pregnant women, smokers, those with asthma or recent respiratory illness, uncontrolled hypertension, or not up-to-date on COVID vaccines are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Exposure
Participants are exposed to either clean air or 0.070 ppm ozone for 6.6 hours while performing moderate intermittent exercise
Immediate Post-Exposure Assessment
Pulmonary function and inflammatory responses are measured immediately after exposure
Follow-up
Participants are monitored for changes in neutrophil levels and lung function 18 hours post-exposure
What Are the Treatments Tested in This Trial?
Interventions
- Exposure to 0.070 ppm Ozone Concentration
- Exposure to Clean Air (0.0 ppm Ozone)
- Moderate Intermittent Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
Martin W. Case
Lead Sponsor
University of North Carolina
Collaborator